Laryngotracheal mucormycosis: Report of a case | Canada Hyperbarics Skip to main content
Case Report Ear Nose Throat J 2016

Laryngotracheal mucormycosis: Report of a case

Mattioni J, Portnoy J, Moore J, Carlson D, Sataloff R — Ear Nose Throat J, 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a case of a 46-year-old man with multiple health conditions who developed a deadly fungal infection called mucormycosis in his larynx and trachea.

What They Found

The patient, an immunocompromised 46-year-old man, developed severe airway obstruction due to mucormycosis, a fungal infection. Despite surgical removal of the infected tissue, the material reaccumulated, and the infection spread widely, leading to the patient's death from other causes weeks later. The management of this type of widespread airway mucormycosis proved challenging and complex.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a case report, this study describes a single patient's experience, which means its findings cannot be broadly applied to all patients with mucormycosis.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 26829683
Year Published 2016
Journal Ear Nose Throat J
MeSH Terms Antifungal Agents; Burkitt Lymphoma; Debridement; Dysphonia; Echinocandins; HIV Infections; Hepatitis C, Chronic; Humans; Hyperbaric Oxygenation; Laryngitis; Laryngoscopy; Lipopeptides; Male; Micafungin; Middle Aged; Mucormycosis; Neurosyphilis; Respiratory Distress Syndrome; Respiratory Sounds; Tracheitis; Tracheotomy; Triazoles

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology